When you have cancer act as if there is no tomorrow, believe you will live forever; focus on your life not on the disease

Daniel Weber M health Sci.


Daniel Weber began his study of Oriental Medicine in 1969 in Boston. He studied with J. R. Worsley and J. D. van Buren in the UK from 1974 before receiving his B.Ac. Daniel went to Japan in 1976 and studied with Dr. Masahiro Oki and Dr. Okada. He has been in practice in Sydney Australia since 1977 and created the first English language data base for Chinese herbal medicine in 1992. This data base was awarded 'Innovations in Australian Design' and put on exhibit in the Powerhouse Museum.

Daniel has studied in China from 1988, visiting more than a dozen times with numerous awards and two honorary Ph.Ds as well as being an advisor to Hangzhou TCM Institute in Hangzhou. Daniel has a Master of Health Science (Aust) and is completing his research Doctorate. Daniel is not just an academic but a committed clinician, and continues a clinic as well as his ongoing studies. His research into complimentary cancer treatments and his seminars to practitioners in Australia, South Africa and the US have attracted positive comment from leaders in the field. He is committed to creating a dialogue between all types of health care professionals.

Curcumin and cancer formation




The benefits are shown in all stages of cancer formation: initiation, promotion and progression.

-Inhibits the formation of cancer causing nitrosamines

-enhances the body's production of cancer fighting compounds such as glutathione

-promotes the liver's proper detoxification of cancer causing compounds

-prevents over production of cyclooxygenase 2 (cox2) *1-5

Curcumin inhibits cancer growth:

-Inhibiting epidermal growth factor *4

-Inhibiting angiogenesis *5

-Inhibiting nuclear factor kappa beta (NF-kb) *4

-Increasing expression of the nuclear p53 protein *4

-Inhibiting growth promoting enzymes *4

Experimental studies have found curcumin fights tumours arising from prostate, breast, skin, colon, stomach and liver cancers.*6-13

*1 Li, JK, Lin-Shia SY. Mechanisms of cancer chemoprevention by curcumin. Proc Natl Sci Counc Republic of China B 2001; 25:59-66

*2 Chen H, Zhang ZS, Zhang YL, Zhou DY. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing aptosis. Anticancer res 1999; 19:3675-80

*3Menon LG, Kuttan R, Kuttan G. Anti-metaatatic activity of curcumin and catechin. Cancer lett 1999; 141:159-65

*4 Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S. Curcumin causes the growth arrest and aptosis of B cell lymphoma by downregulation of erg-, c-myc, bcl-XL, NF-kappa B, and p53. Clin immunol 1999; 93:152-61

*5 Arbiser JL, Klauber N, Rohan R, et al. Curcumin ia an in vivo inhibitor of angiogenesis. Mol Med 1998; 4:376-83

Other references upon request